One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development
Science Advances · 2026
DOI: 10.1126/sciadv.adv1554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Nathan A Ona und 26 weiteren Autor:innen. Beteiligte Einrichtung: Institute for RNA Innovation, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Dendrimers, RNA, Messenger, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Science Foundation, National Institutes of Health, Wellcome Leap.
Abstract (Originalsprache)
There have been rapid advances in nucleoside-modified messenger RNA–based vaccines, particularly during the SARS-CoV-2 pandemic, demonstrating a rapid and cost-effective approach for addressing infectious diseases. A major challenge remains in developing a delivery system that protects mRNA from degradation and facilitates its passage through tissue and cellular barriers. Current four-component lipid nanoparticles enable efficient endosomal escape and are a pivotal technology for the delivery of mRNA vaccines. However, challenges such as stability, availability, durability, and adverse effects persist. We have developed a self-assembling one-component ionizable amphiphilic Janus dendrimers (IAJD) delivery system with naturally occurring amino heads, capable of efficiently delivering mRNA to the spleen and lymph nodes. This single-component system simplifies synthesis, reduces development complexity, and enables rapid global distribution of mRNA vaccines during pandemics. As a proof of concept, one-component IAJD97, formulated with mRNA encoding norovirus mRNA capsid protein, demonstrates the potential of IAJDs as efficient delivery platform for mRNA vaccines, advancing their effectiveness and expanding applications to improve public health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for RNA Innovation, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Infectious Disease Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, China.
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Jiao Tong University, Shanghai, China.
- Roy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Nathan A Ona, Dapeng Zhang, Lisa C Lindesmith, Wook-Jin Park, Jaclynn A Meshanni, Sydni Berkihiser, Jessica A Vasserman, Nathanael C Moore, Benjamin Nakagawa, Xiomara Mercado-López, Wendy Bonilla-Acosta, Paul D Brewer-Jensen, Mark R Zweigart, Yaoska I Reyes, Michael L Mallory, Yongfeng Zhou, Virgil Percec, Ralph S Baric, Drew Weissman, Elena N Atochina-Vasserman
Förderung
- National Science Foundation
- National Institutes of Health
- Wellcome Leap
Zitieren
APA
Ona, N. A., Zhang, D., Lindesmith, L. C., Park, W. J., Meshanni, J. A., Berkihiser, S., Vasserman, J. A., Toshtzar, S., Moore, N. C., Williams, B., Nakagawa, B., Baboo, I., Pan, L., Cheng, W., Mercado-López, X., Bonilla-Acosta, W., Brewer-Jensen, P. D., Zweigart, M. R., Reyes, Y. I., …, & Atochina-Vasserman, E. N. (2026). One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development. Science Advances. https://doi.org/10.1126/sciadv.adv1554
Vancouver
Ona NA, Zhang D, Lindesmith LC, Park WJ, Meshanni JA, Berkihiser S, et al. One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development. Science Advances. 2026. doi:10.1126/sciadv.adv1554
BibTeX
@article{Ona2026,
author = {Ona, Nathan A and Zhang, Dapeng and Lindesmith, Lisa C and Park, Wook-Jin and Meshanni, Jaclynn A and Berkihiser, Sydni and Vasserman, Jessica A and Toshtzar, Sepideh and Moore, Nathanael C and Williams, Blair and Nakagawa, Benjamin and Baboo, Ishana and Pan, Liuyan and Cheng, Wanting and Mercado-López, Xiomara and Bonilla-Acosta, Wendy and Brewer-Jensen, Paul D and Zweigart, Mark R and Reyes, Yaoska I and Mallory, Michael L and May, Samantha R and Zhou, Yongfeng and Percec, Virgil and Baric, Ralph S and Li, Yongsheng and Weissman, Drew and Atochina-Vasserman, Elena N},
title = {One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adv1554}
}
EUVIMED